We have perennially been on opposite sides of the table from the Center for Science in the Public Interest (CSPI) on virtually every issue, for example, artificial sweeteners, trace chemicals, Continue reading →
The latest in health news: The Pennsylvania Environmental Protection Agency releases review on low-risk fracking, a stem cell transplant method provides new hope for MS treatment, & why Golden Rice mustn’t be stopped.
The latest in health news: Why a sedentary lifestyle is deadly, but pizza consumption isn’t, and Dr. Ross’s latest op-ed in The Daily Caller discussing the sad state of our nation’s public health when it comes to stemming the toll of cigarette smoking.
An opinion piece in Sunday’s NYTimes by ACSH friend, psychiatrist Sally Satel, paints the sad picture of the e-cigarette wasteland if the FDA’s proposed e-cig regulations get adopted. Continue reading →
Dr. Gilbert Ross in The Daily Caller, January 19, 2015.
Just when I thought the state of America’s public health regarding smoking could not get any worse, the California Department of Public Health (CDPH) showed me how wrong I was. Their new leaflet: Protect Your Continue reading →
We have written about the antibiotic crisis quite often, both in Dispatch and published op-eds. Many others have done the same.
Although much of the focus has been on the development of new antibiotics to combat resistant bacteria, there are other fronts in this war. Although the need for antibiotics is undisputed, it is better not to need them in the first place. This is an area in which good progress has been made. Continue reading →
In his op-ed in the Wall Street Journal, Dr. Henry Miller reminisces, sardonically, about the vast potential — wasted — of “biopharming”: genetically modifying plants to make pharmaceuticals. The regulators choked it to death. Continue reading →
As reported in today’s Wall Street Journal, an FDA advisory panel has voted unanimously to recommend the approval of a “new” product from Novartis called Zarxio. Assuming that the FDA follows the panel’s advice (they usually do), a bit of pharmaceutical history will be made—the ability of companies to develop and market biologic drugs that are similar to those of other companies. Continue reading →
Dr. Gilbert Ross in the Detroit Free Press, January 6, 2015.
What a topsy-turvy world we live in: the only groups opposed to keeping kids away from e-cigarettes are the so-called “public health” groups. If we can agree that youngsters and e-cigarettes shouldn’t mix — at least not Continue reading →